These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10577972)

  • 41. Early structural changes in cartilage and bone are required for the attachment and invasion of inflamed synovial tissue during destructive inflammatory arthritis.
    Korb-Pap A; Stratis A; Mühlenberg K; Niederreiter B; Hayer S; Echtermeyer F; Stange R; Zwerina J; Pap T; Pavenstädt H; Schett G; Smolen JS; Redlich K
    Ann Rheum Dis; 2012 Jun; 71(6):1004-11. PubMed ID: 22258493
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1.
    Koenders MI; Lubberts E; Oppers-Walgreen B; van den Bersselaar L; Helsen MM; Di Padova FE; Boots AM; Gram H; Joosten LA; van den Berg WB
    Am J Pathol; 2005 Jul; 167(1):141-9. PubMed ID: 15972960
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proteasome inhibition aggravates tumor necrosis factor-mediated bone resorption in a mouse model of inflammatory arthritis.
    Polzer K; Neubert K; Meister S; Frey B; Baum W; Distler JH; Gückel E; Schett G; Voll RE; Zwerina J
    Arthritis Rheum; 2011 Mar; 63(3):670-80. PubMed ID: 21360496
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-interleukin-1 and anti-CD44 interventions producing significant inhibition of cartilage destruction in an in vitro model of cartilage invasion by rheumatoid arthritis synovial fibroblasts.
    Neidhart M; Gay RE; Gay S
    Arthritis Rheum; 2000 Aug; 43(8):1719-28. PubMed ID: 10943861
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-inflammatory effects of systemic anti-tumour necrosis factor alpha treatment in human/murine SCID arthritis.
    Schädlich H; Ermann J; Biskop M; Falk W; Sperling F; Jüngel A; Lehmann J; Emmrich F; Sack U
    Ann Rheum Dis; 1999 Jul; 58(7):428-34. PubMed ID: 10381487
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fcgamma receptors directly mediate cartilage, but not bone, destruction in murine antigen-induced arthritis: uncoupling of cartilage damage from bone erosion and joint inflammation.
    van Lent PL; Grevers L; Lubberts E; de Vries TJ; Nabbe KC; Verbeek S; Oppers B; Sloetjes A; Blom AB; van den Berg WB
    Arthritis Rheum; 2006 Dec; 54(12):3868-77. PubMed ID: 17133594
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interleukin-6 reduces cartilage destruction during experimental arthritis. A study in interleukin-6-deficient mice.
    van de Loo FA; Kuiper S; van Enckevort FH; Arntz OJ; van den Berg WB
    Am J Pathol; 1997 Jul; 151(1):177-91. PubMed ID: 9212744
    [TBL] [Abstract][Full Text] [Related]  

  • 48. IL-3 Decreases Cartilage Degeneration by Downregulating Matrix Metalloproteinases and Reduces Joint Destruction in Osteoarthritic Mice.
    Kour S; Garimella MG; Shiroor DA; Mhaske ST; Joshi SR; Singh K; Pal S; Mittal M; Krishnan HB; Chattopadhyay N; Ulemale AH; Wani MR
    J Immunol; 2016 Jun; 196(12):5024-35. PubMed ID: 27183574
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation of cannabinoid receptor 2 attenuates synovitis and joint distruction in collagen-induced arthritis.
    Gui H; Liu X; Liu LR; Su DF; Dai SM
    Immunobiology; 2015 Jun; 220(6):817-22. PubMed ID: 25601571
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Experimental model of temporomandibular joint arthritis: Evaluation of contralateral joint and masticatory muscles.
    Lemos GA; da Silva PLP; Batista AUD; Palomari ET
    Arch Oral Biol; 2018 Nov; 95():79-88. PubMed ID: 30071410
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparative study into the mechanisms of action of anti-tumor necrosis factor alpha, anti-CD4, and combined anti-tumor necrosis factor alpha/anti-CD4 treatment in early collagen-induced arthritis.
    Marinova-Mutafchieva L; Williams RO; Mauri C; Mason LJ; Walmsley MJ; Taylor PC; Feldmann M; Maini RN
    Arthritis Rheum; 2000 Mar; 43(3):638-44. PubMed ID: 10728758
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A model of inflammatory arthritis highlights a role for oncostatin M in pro-inflammatory cytokine-induced bone destruction via RANK/RANKL.
    Hui W; Cawston TE; Richards CD; Rowan AD
    Arthritis Res Ther; 2005; 7(1):R57-64. PubMed ID: 15642143
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hyperleptinemia suppresses aggravation of arthritis of collagen-antibody-induced arthritis in mice.
    Okano T; Koike T; Tada M; Sugioka Y; Mamoto K; Inui K; Okihana H; Ebihara K; Nakao K; Nakamura H
    J Orthop Sci; 2015 Nov; 20(6):1106-13. PubMed ID: 26293802
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Current aspects of the immunology of articular cartilage].
    Miossec P; Sany J
    Rev Rhum Mal Osteoartic; 1987; 54(7-9):595-600. PubMed ID: 3313671
    [No Abstract]   [Full Text] [Related]  

  • 56. Analysis of the cytokine network among tumor necrosis factor alpha, interleukin-1beta, interleukin-8, and interleukin-1 receptor antagonist in monosodium urate crystal-induced rabbit arthritis.
    Matsukawa A; Yoshimura T; Maeda T; Takahashi T; Ohkawara S; Yoshinaga M
    Lab Invest; 1998 May; 78(5):559-69. PubMed ID: 9605181
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhanced neutrophil extravasation and rapid progression of proteoglycan-induced arthritis in TSG-6-knockout mice.
    Szántó S; Bárdos T; Gál I; Glant TT; Mikecz K
    Arthritis Rheum; 2004 Sep; 50(9):3012-22. PubMed ID: 15457471
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of interleukin 1 in antigen-induced exacerbations of murine arthritis.
    van de Loo AA; Arntz OJ; Bakker AC; van Lent PL; Jacobs MJ; van den Berg WB
    Am J Pathol; 1995 Jan; 146(1):239-49. PubMed ID: 7856731
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interleukin 1 or tumor necrosis factor-alpha: which is the real target in rheumatoid arthritis?
    Dayer JM
    J Rheumatol Suppl; 2002 Sep; 65():10-5. PubMed ID: 12236616
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction of cartilage damage by overexpression of T cell interleukin-17A in experimental arthritis in mice deficient in interleukin-1.
    Koenders MI; Lubberts E; Oppers-Walgreen B; van den Bersselaar L; Helsen MM; Kolls JK; Joosten LA; van den Berg WB
    Arthritis Rheum; 2005 Mar; 52(3):975-83. PubMed ID: 15751058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.